JCJitendra Singh Chaudhary

Jitendra Singh Chaudhary

*This is an algorithmically generated author record based on publicly available information.

Jitendra Singh Chaudhary has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transforming RNA-Based Gene Therapy with Innovative Nanocarriers for siRNA and miRNA Delivery

    by Jitendra Singh Chaudhary, Dilip Kumar Chanchal, Kuldeep Singh, Jeetendra Kumar Gupta, Divya Jain, Anubhav Dubey, Mahima Pandey, Shahbaz Khan

    The cells have been given precise instructions proprio to the regulation of gene expression by the main genesis of Ryan-based gene therapy, which has revived cancer treatment and other disorders. The difficulty of delivering small interfering RNA (siRNA) and microRNA (miRNA) to a target cell is an enormous task and is often faced by researchers due to characteristic instabilities of these carriers and their poor uptake by the cell membrane. The new developments from nanocarrier technologies offer opportunities for better effectiveness of RNA therapy for its delivery and the effectiveness of the treatment regimen. The objective of this article is to provide an overview of the existing as well as the newest developments in nanocarrier technology, particularly as related to microRNA and small interfering RNA (siRNA) delivery. Their modes of operation and their uses in gene therapies are also examined as principles of their design. We focus on several nanocarrier technologies, which have shown proof of concept in multiple disciplines such as stability, controlled release profiles, and delivery. Lipid-based nanoparticles, polymeric systems, and hybrid nanocarriers are some of the platforms that fall under this category; however, this list is not exhaustive. We also study the idea that certain nanocarriers could have multiple functionalities, which would make it possible to improve cancer treatment by simultaneously carrying chemotherapy and genes. We aim to shed light on the future of RNA-based gene therapy by providing a thorough overview of recent research in the field. This will help us understand how novel nanocarrier technologies can tackle the delivery issues.

  • Exploring the Synergistic Antimicrobial Potential of Garlic and Honey: A Comprehensive Review

    by Priti Yadav, Surendra Lalwani, Dilip Kumar Chanchal, Nidhi Mittal, Jitendra Singh Chaudhary

    Aims: This article explores the well-established therapeutic attributes of honey and garlic, renowned for their potent antibacterial effects. This investigation aims to elucidate the synergistic antibacterial potential resulting from the combined use of these two natural substances. Methods: A comprehensive examination of honey's antibacterial and antifungal characteristics is conducted, delineating its intricate mechanism of action with a focus on hydrogen peroxide and other phytochemicals. Simultaneously, various processes underpinning the antibacterial properties of garlic are discussed, with particular emphasis on its key bioactive component, allicin. Results: This research unveils a novel perspective on the interaction between honey and garlic. It is intricately analyzed how garlic's bioactive components disrupt microbial cell membranes, while honey employs diverse tactics to combat illnesses. This interaction opens new possibilities for modern antibacterial approaches. Discussion: Quantitative findings and the significance of the study are discussed in detail. The practical applications of the synergistic antibacterial potential are underscored, emphasizing its relevance in food preservation and medicinal contexts. The research accentuates the promising use of garlic and honey blends as natural alternatives to artificial preservatives, with implications for wound care and infection prevention. Conclusion: Emphasizing the valuable applications of synergistic antibacterial potential across diverse industries, including food preservation and medicine, this study underscores the importance of harnessing the combined antibacterial qualities of garlic and honey as a sustainable solution to emerging challenges in food safety and health.

  • Strategies to Enhance Ocular Penetration of Drugs in Controlled Release Formulations

    by Devesh Singh, Akhilesh Kumar Mishra, Khushboo Mishra, Dilip Kumar Chanchal, Jitendra Singh Chaudhary

    Objective:: The purpose of this study is to provide a thorough examination of methods for improving ocular medication penetration within controlled-release formulations, with an emphasis on their relevance to the treatment of eye disorders. Method:: Employing a methodical and rigorous methodology, this study provides an in-depth survey of current knowledge and research on the topic. Research on iontophoresis, prodrugs, pH modulation, penetration enhancers, hydrogels, inserts, nanomicelles, microemulsions, dendrimers, contact lenses, cationic emulsions, and targeted drug delivery are only some of the many topics covered in this study. Results:: Results summarise and synthesize prior research to give useful insights into the efficacy and potential of controlled-release formulations in increasing ocular medication delivery, providing a thorough review of current insights into these techniques. Discussion:: The discussion portion of the review critically assesses the guiding principles, advantages, and downsides of each technique, and it also investigates the consequences and prospects for this developing subject. Conclusion:: The study highlights the revolutionary potential of controlled-release formulations in the treatment of ocular illnesses, highlighting the importance of overcoming the obstacles associated with restricted pharmaceutical penetration into ocular tissues. This study concludes the present level of knowledge and paves the way for future improvements in the area of ocular medication administration, making it an essential resource for scientists and medical professionals working on the subject.


  • Nanostructures and Niosomes: A Quantum Leap in Clotrimazole Therapeutics

    by Himanshu Gupta, Jitendra Singh Chaudhary, Dilip Kumar Chanchal

    This in-depth analysis examines the revolutionary potential of nanostructures, particularly niosomes, in boosting Clotrimazole's therapeutic effectiveness for dermatological applications. A common antifungal drug called clotrimazole suffers significant problems with solubility, bioavailability, and penetration. Niosomal gels in particular, which are nanostructured drug carriers, have emerged as ground-breaking approaches to overcome these constraints. The study opens with an explanation of the mechanisms of action of Clotrimazole and its wide range of therapeutic uses in dermatology, emphasising the limitations of standard formulations. We present and explore niosomes, lipid-based nanocarriers with diverse characteristics. They provide a viable substrate for improved Clotrimazole administration due to their biocompatibility, adjustable lipid composition, and capacity to encapsulate both hydrophilic and hydrophobic medications. The creation and development of clotrimazole- loaded niosomal gels are at the core of the review. Numerous preparation processes are investigated, and elements affecting the formation of niosomal gel, such as lipid content and optimization strategies, are reviewed. Particle size analysis and encapsulation efficiency testing are two methods for characterising these gels that are covered in depth. The effectiveness of Clotrimazoleloaded niosomal gels is validated in large part by in vitro and in vivo tests. The review explores in vitro drug release investigations, studies of skin permeability and penetration, and comparisons with conventional formulations. When accessible, preclinical and clinical trial insights provide crucial clinical context. The benefits of clotrimazole-loaded niosomal gels, such as greater patient compliance and improved drug delivery, are also covered in the article. It solves difficulties including stability issues and regulatory issues. The review's conclusion emphasises the essential role that nanostructures and niosomes have played in developing Clotrimazole medicines for dermatological usage. It provides a thorough review of current developments, exciting new approaches, and the wider effects of this ground-breaking medication delivery strategy.


  • CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

    by Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, Neha Agnihotri, Prateek Porwal

    With the discovery of CRISPR-Cas9, drug development and precision medicine have undergone a major change. This review article looks at the new ways that CRISPR-based therapies are being used and how they are changing the way medicine is done. CRISPR technology's ability to precisely and flexibly edit genes has opened up new ways to find, validate, and develop drug targets. Also, it has made way for personalized gene therapies, precise gene editing, and advanced screening techniques, all of which hold great promise for treating a wide range of diseases. In this article, we look at the latest research and clinical trials that show how CRISPR could be used to treat genetic diseases, cancer, infectious diseases, and other hard-to-treat conditions. However, ethical issues and problems with regulations are also discussed in relation to CRISPR-based therapies, which shows how important it is to use them safely and responsibly. As CRISPR continues to change how drugs are made and used, this review shines a light on the amazing things that have been done and what the future might hold in this rapidly changing field.